{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:24:11Z","timestamp":1788387851156,"version":"build-2803163510"},"reference-count":32,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate treatment patterns and clinical outcomes among patients with multiple myeloma treated at a major cancer center in Kazakhstan over a 10-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective observational study analyzed data from 261 patients with multiple myeloma treated at the National Research Oncology Center, Astana, between 2010 and 2021. Sociodemographic and clinical characteristics, treatment regimens, and survival outcomes were assessed using data from electronic medical records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most patients were diagnosed with stage II of multiple myeloma, based on the Durie\u2013Salmon staging system, and the majority received bortezomib plus dexamethasone as first-line treatment. Hematopoietic stem cell transplantation was performed in 117 (45%) patients, with a 5-year overall survival rate of 63.6%, compared with 46.2% in patients who received chemotherapy alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The mean age of this cohort was 54 years, suggesting an earlier onset of multiple myeloma in the Kazakh population. Treatment regimens, stem cell yield, and post-transplant complications significantly influenced survival outcomes, underscoring the need to optimize transplant strategies and supportive care in Kazakhstan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03000605251411783","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:40:42Z","timestamp":1769175642000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Hematopoietic stem cell transplantation for multiple myeloma in Kazakhstan: Ten-year single-center experience"],"prefix":"10.1177","volume":"54","author":[{"given":"Vadim","family":"Kemaykin","sequence":"first","affiliation":[{"name":"National Research Oncology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhandos","family":"Burkitbayev","sequence":"additional","affiliation":[{"name":"National Research Oncology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azat","family":"Karabekov","sequence":"additional","affiliation":[{"name":"National Research Oncology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kolesnikova","sequence":"additional","affiliation":[{"name":"National Research Oncology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnur","family":"Zhakhina","sequence":"additional","affiliation":[{"name":"School of Medicine, Nazarbayev University, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamilya","family":"Saparbay","sequence":"additional","affiliation":[{"name":"Oncohepatology and Organ Transplantation, National Research Oncology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzal","family":"Vildanova","sequence":"additional","affiliation":[{"name":"National Research Oncology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigerim","family":"Idrisova","sequence":"additional","affiliation":[{"name":"National Research Oncology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinara","family":"Zharlyganova","sequence":"additional","affiliation":[{"name":"National Research Oncology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9578-4236","authenticated-orcid":false,"given":"Zhuldyz","family":"Kuanysh","sequence":"additional","affiliation":[{"name":"National Research Oncology Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(10)70003-5"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0002"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31937"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0141"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.11.007"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12790"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp14X680737"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607113350204"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022340"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb06890.x"},{"key":"e_1_3_7_13_2","first-page":"99","article-title":"Front line treatment of elderly multiple myeloma in the era of novel agents","volume":"3","author":"Venon MD","year":"2009","unstructured":"Venon MD, Roccaro AM, Gay J, et\u00a0al. Front line treatment of elderly multiple myeloma in the era of novel agents. Biologics 2009; 3: 99\u2013109.","journal-title":"Biologics"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_7_15_2","unstructured":"Republican Center for Health Development. Multiple myeloma and malignant plasma cell neoplasms. Clinical Protocols of the Ministry of Health of the Republic of Kazakhstan\u20142018. Astana: Ministry of Health of the Republic of Kazakhstan; 2019. Protocol No. 74. (Archived version). https:\/\/diseases.medelement.com\/disease\/\u043c\u043d\u043e\u0436\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u0430\u044f-\u043c\u0438\u0435\u043b\u043e\u043c\u0430-\u0438-\u0437\u043b\u043e\u043a\u0430\u0447\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0435-\u043f\u043b\u0430\u0437\u043c\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u044b\u0435-\u043d\u043e\u0432\u043e\u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f-2019\/16297 (accessed 21 September 2025)."},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200312"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10091809"},{"key":"e_1_3_7_18_2","first-page":"470","article-title":"The diagnosis and treatment of multiple myeloma","volume":"113","author":"Gerecke C","year":"2016","unstructured":"Gerecke C, Fuhrmann S, Strifler S, et\u00a0al. The diagnosis and treatment of multiple myeloma. Dtsch Arztebl Int 2016; 113: 470\u2013476.","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/03000605251326804"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.1060"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.3463"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.18620\/ctt-1866-8836-2016-5-4-21-31"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02002-x"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-017-0876-y"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71068"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-024-03754-8"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13615-0"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17091389"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.63"},{"key":"e_1_3_7_31_2","article-title":"Second primary malignancies post autologous stem-cell transplant in multiple myeloma from India: knowing the unknown","author":"Mirgh S","year":"2025","unstructured":"Mirgh S, Surendran A, Punatar S, et\u00a0al. Second primary malignancies post autologous stem-cell transplant in multiple myeloma from India: knowing the unknown. Indian J Hematol Blood Transfus 2025;","journal-title":"Indian J Hematol Blood Transfus"},{"key":"e_1_3_7_32_2","first-page":"316","article-title":"Second stem cell transplantation for treatment of relapsed\/refractory multiple myeloma after first autologous stem cell transplant: a 15-year retrospective institutional analysis","volume":"60","author":"Yadav N","year":"2023","unstructured":"Yadav N, Mirgh SP, Aggarwal M, et\u00a0al. Second stem cell transplantation for treatment of relapsed\/refractory multiple myeloma after first autologous stem cell transplant: a 15-year retrospective institutional analysis. Indian J Cancer 2023; 60: 316\u2013324. https:\/\/doi.org\/10.4103\/ijc.IJC_272_21.","journal-title":"Indian J Cancer"},{"key":"e_1_3_7_33_2","unstructured":"Republican Center for Health Development. Multiple myeloma and malignant plasma cell neoplasms. Clinical Protocols of the Ministry of Health of the Republic of Kazakhstan\u20142022. Astana: Ministry of Health of the Republic of Kazakhstan; 2023. Protocol No. 179. https:\/\/diseases.medelement.com\/disease\/\u043c\u043d\u043e\u0436\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u0430\u044f-\u043c\u0438\u0435\u043b\u043e\u043c\u0430-\u0438-\u0437\u043b\u043e\u043a\u0430\u0447\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0435-\u043f\u043b\u0430\u0437\u043c\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u044b\u0435-\u043d\u043e\u0432\u043e\u043e\u0431\u0440\u0430\u0437\u043e\u0432\u0430\u043d\u0438\u044f-\u043a\u043f-\u0440\u043a-2023\/17547 (accessed 21 September 2025)."}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605251411783","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03000605251411783","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605251411783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:48:28Z","timestamp":1777459708000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03000605251411783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1177\/03000605251411783"],"URL":"https:\/\/doi.org\/10.1177\/03000605251411783","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"03000605251411783"}}